Nested case-control study of occupational chemical exposures and prostate cancer in aerospace and radiation workers by Krishnadasan, Anusha et al.
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE 50:383–390 (2007)
Nested Case-Control Study of Occupational
Chemical Exposures and Prostate Cancer in
Aerospace and Radiation Workers
Anusha Krishnadasan, PhD,1 Nola Kennedy, PhD,2 Yingxu Zhao, PhD,1
Hal Morgenstern, PhD,3 and Beate Ritz, MD, PhD1,2
Background To date, little is known about the potential contributions of occupational
exposure to chemicals to the etiology of prostate cancer. Previous studies examining
associations suffered from limitations including the reliance on mortality data and
inadequate exposure assessment.
Methods We conducted a nested case-control study of 362 cases and 1,805 matched
controls to examine the association between occupational chemical exposures and
prostate cancer incidence. Workers were employed between 1950 and 1992 at a nuclear
energy and rocket engine-testing facility in Southern California. We obtained cancer-
incidence data from theCaliforniaCancerRegistry and seven other state cancer registries.
Data from company records were used to construct a job exposure matrix (JEM) for
occupational exposures to hydrazine, trichloroethylene (TCE), polycyclic aromatic
hydrocarbons (PAHs), benzene and mineral oil. Associations between chemical exposures
and prostate cancer incidence were assessed in conditional logistic regression models.
Results With adjustment for occupational confounders, including socioeconomic status,
occupational physical activity, and exposure to the other chemicals evaluated, the odds
ratio for low/moderate TCE exposure was 1.3; 95%CI¼ 0.8 to 2.1, and for high TCE
exposure was 2.1; 95%CI¼ 1.2 to 3.9. Furthermore, we noted a positive trend between
increasing levels of TCE exposure and prostate cancer (P-value for trend¼ 0.02).
Conclusion Our results suggest that high levels of TCE exposure are associated
with prostate cancer among workers in our study population. Am. J. Ind. Med. 50:383–
390, 2007.  2007 Wiley-Liss, Inc.
KEY WORDS: occupational chemical exposure; prostate cancer; job exposure
matrix; trichloroethylene; nested case-control study
INTRODUCTION
It has previously been reported that occupational
exposure to certain chemicals may increase prostate cancer
risk [Parent and Siemiatycki, 2001]. For example, elevated
risks have been reported for exposure to cadmium, polycyclic
aromatic hydrocarbons (PAHs), engine emissions, asbestos,
and chemicals involved in metalworking, work in the rubber
industry, fire fighting, and farming and agriculture [Van der
Gulden et al., 1992; Krstev et al., 1998; Parent and
Siemiatycki, 2001]. However, to date there is no consensus
that any of these agents cause prostate cancer partly due to
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limitations of many previous studies such as their reliance on
mortality data and inadequate exposure assessment.
Occupational cohort studies that rely on mortality data
for measuring outcomes [Boice et al., 2006; Brown and
Delzell, 2000; Collins et al. 1999; Marsh et al., 2001; Ritz,
1999; Weston et al., 2000; Whorton et al., 1998] are limited
by the fact that prostate cancer is typically a non-fatal
cancer. The survival rate for prostate cancer is high (90% in
the U.S.), [Grossfield and Carroll, 2001] and the number of
cancer deaths low relative to the number of incident cases.
Consequently, such studies usually lack statistical power
and render results inconclusive [Costantino et al., 1995].
Moreover, findings might not be an accurate reflection of
etiologic factors, but may instead be related to factors
associated with fatality [Demers et al., 1992].
Studies that utilize job titles or categories as a proxy for
exposure to chemicals might be prone to considerable
exposure misclassification and inefficiency [Checkoway
et al., 1987; Elghany et al., 1990; Sharma-Wagner, 2000].
This affects registry-based studies especially, since generic
job titles or industries (such as farming, metal work, etc.)
often represent a great range of possible chemicals and
exposure levels. Industry-based studies that can access
employment records and other data sources for exposure
assessment and allow the creation of a job exposure matrix
(JEM) usually improve exposure assessment [Goldberg et al.,
1993]; but such studies often do not have access to or are
unable to collect information on potential non-occupational
confounding risk factors [Dosemeci et al., 1993; Hsing et al.,
1994; Krstev et al., 1998; Buxton et al., 1999; Brown and
Delzell, 2000; Norman et al., 2002].
We attempted to address some of these shortcomings, by
conducting a nested case-control study of prostate cancer
incidence among former workers of a nuclear energy and
rocket engine development and testing facility. A statewide
cancer registry in California established in 1988 provided us
with 12 years of prostate cancer incidence data. We were able
to employ company records, retired worker interviews, and
industrial hygiene review to construct an industry-based JEM
and estimate exposures to selected known or suspected
carcinogens commonly used at the facility. These resources
were also used to assess exposure to other occupational
risk factors and potential confounding factors, including
physical activity levels at work and pay status as a proxy for
socioeconomic status (SES). Finally, we conducted a survey
among a subset of living workers to collect data on
potentially confounding lifestyle factors.
MATERIALS AND METHODS
Study Population
Selection of subjects has been previously described [Ritz
et al., 2000, 2006]. Briefly, subjects were selected from two
worker cohorts, which were assembled in the early1990’s to
study whether exposure to radiation and hydrazine were
related to cancer mortality [Ritz et al., 2000; Morgenstern
and Ritz, 2001]. Workers were employed between 1950 and
1993 at a rocket engine and nuclear power testing facility
in Los Angeles County. The radiation cohort consisted of
4,607 workers enrolled in the company’s radiation monitor-
ing program, who were primarily involved in research and
development of nuclear power systems. The aerospace
cohort consisted of 6,107 workers who were involved in
rocket engine development and testing. The aerospace cohort
was restricted to men employed for at least two years and who
started their employment before 1980. For the present
prostate cancer study, all women were excluded from the
radiation cohort (n¼ 276). We excluded 1,410 workers from
both cohorts who died before 1988 according to data from
company retirement beneficiary records, the U.S. Social
Security administration, California mortality records, and the
U.S. National Death Index (NDI).
Eight cancer registries were searched to identify
392 cases of prostate cancer diagnosed between January 1,
1988 and December 31, 1999: 337 from California;
8 from Nevada; 12 from Arizona; 6 from Texas; 15 from
Washington; 11 from Florida; 2 from Arkansas; and 1 from
Oregon. Necessary approvals from Human Subjects com-
mittees in all states were obtained to access these data.
Cancer registry coverage was incomplete during the follow-
up period in four states: Texas (coverage period: 1996–
1999), Washington (1992–1999), Arkansas (1996–1999),
and Oregon (1996–1999). We were also unable to obtain
cancer incidence data from other U.S. states where 11% of
our workers had died during follow-up, according to NDI
records.
A nested case-control study approach was chosen to
make the record review necessary for exposure assessment
feasible within the limits of funding for this study. Controls
were randomly selected from the original cohorts, using risk-
set sampling. They were matched (5:1) to prostate cancer
cases, on age at start date of employment (2 years), age
at diagnosis (2 years), and which of the two cohorts
they were selected from, i.e., radiation or aerospace. Thus,
initially, 1,896 controls were matched to 392 prostate cancers
diagnosed and identified during follow-up.
After obtaining additional information during our
record review, we subsequently excluded 1) 105 workers
(17 cases and 88 controls) first employed after 1980 or
having worked for less than 2 years at Rocketdyne to ensure
that workers from both cohorts were similar in terms of
minimum years of employment; 2) two presumed male
controls found to be female; and 3) fourteen cases and one
control found to have received a secondary diagnosis of
prostate cancer within three years of another primary
cancer. The final study population consists of 362 cases and
1,805 controls.
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Exposure Assessment
Details about the JEM have been previously published
[Zhao et al., 2005; Ritz et al., 2006]. Briefly, we compiled a
list of known and suspected carcinogens that were regularly
used at the facility, including hydrazine, trichloroethylene
(TCE), benzene, mineral oil, and polycyclic aromatic
hydrocarbons (PAHs). A JEM for chemical exposures
was developed by our industrial hygienist (IH; N.Kennedy)
and reviewed by an occupational epidemiologist
(B. Ritz); both assembled data for the original cohort
studies and gained knowledge of work practices at the
company by interviewing company personnel and observing
employees.
We extracted information about the longest job held at
the company from personnel records; for 80% of the workers
this was the only job held. We also extracted information for
those with more than one job that either had a high potential
for chemical exposures, or any job held for an equal number
of years as the longest job. This second job was often a junior
level position of their longest job which they had held for two
or three years, e.g., a research engineer may have started
employment as a research assistant, or a test engineer may
have started work as a technician. There were 64 workers
without job title information and we treated these workers as
having been unexposed.
Using job description manuals and the knowledge
gained in walk-through surveys of the facility and worker
and manager interviews, our IH created an estimate of the
likelihood (none, low, high), and intensity (low, medium,
high) of exposure to chemicals for each job title over three
periods: 1950’s and 60’s; 1970’s; and 1980’s and 90’s.
Ratings for each job title were performed blinded to case-
control status of subjects. Duration of employment and the
estimated intensity of chemical exposure in the longest job
held were combined (i.e., multiplied) to create an exposure
score for each chemical. If a worker held a job besides their
longest job held (n¼ 293), this score was created for each job
separately, and then added to create a cumulative exposure
score for each chemical. Since workers in the radiation and
aerospace cohorts were exposed to different levels of
chemicals, exposure assessments for job titles common to
both groups (e.g., research and test engineers) took into
account the work environments.
We also created a JEM for occupational physical activity
using a 5-point intensity scale for three different time periods
(1950’s and 60’s, 1970’s, and 1980’s and 90’s; Krishnadasan
A, et al., manuscript in review). Jobs with a score of ‘3’ or
greater were classified as ‘high’ activity (walking with heavy
and light manual work); a score of ‘2’ represented ‘moderate’
activity (sitting and standing with some walking); and a score
of ‘1’ ‘low’ activity (mainly sitting). Pay status information
obtained from company records were used to categorize
workers into three SES groups: 1) professional/salaried
workers, 2) non-professional/salaried workers, and 3) hourly
workers.
Survey Population
We obtained address and telephone information using
on-line information services for 734 workers249 cases and
485 matched controls (using the same matching criteria as for
the nested case-control study population) – all of whom were
still alive in 1999. We received mailed questionnaires and/or
interviewed 338 workers (140 cases and 248 controls), but
were unable to obtain information from the remaining
workers because of death (13%), refusal (17%), missing
contact information (12%), and nonresponse (11%). In
this survey, we asked subjects to describe recreational
physical activity at different periods over their lifetime:
ages 18–25, ages 25–44, ages 45–64, and over age 65.
We also obtained information on race, weight and height
history (to calculate body mass index), smoking history,
education, diabetes, family history of prostate cancer, and
whether they underwent regular screening for prostate
cancer.
Statistical Analysis
We employed risk set analysis; therefore, new risk sets
were created by selecting all workers who were at risk for
prostate cancer at the time of each case diagnosis. For all
members in a riskset, exposures to chemicals were only
considered up to the date of diagnosis of the case, which
enabled us to address time-dependent exposures, i.e.,
chemicals used at the facility. Variables that we originally
matched on to select the study population were entered into
all models as covariates [Breslow and Day, 1980; Rothman
and Greenland, 1998].
We created categories of exposure (none, low, moderate
and high) for each chemical using the quartile cut point
values of the cumulative exposure scores among exposed
workers. The unexposed workers were considered the
referent group in data analyses. Since associations were
similar at low and moderate exposure levels these two
categories were combined for each chemical.
Some chemical exposures were strongly correlated, e.g.,
88% of workers exposed to TCE were also exposed to PAHs
(Pearson correlation coefficient (r)¼ 0.82, P< 0.001), 87%
exposed to hydrazine were also exposed to TCE (r¼ 0.88,
P< 0.001), 92% exposed to mineral oil were also exposed to
TCE (r¼ 0.74, P< 0.001), and 98% exposed to benzene
were also exposed to PAHs (r¼ 0.94, P< 0.001). Therefore,
multicollinearity among the chemical exposures could result
in imprecision and instability of estimates if entered into the
same model.
First, we estimated odds ratios and 95% confidence
intervals for prostate cancer employing conditional logistic
regression models for each chemical exposure adjusting for
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matching variables only. In addition, to account for possible
mutual confounding between chemicals and other occupa-
tional risk factors, we examined the association of each
chemical and prostate cancer risk adjusting for matching
variables, other occupational factors (occupational physical
activity and SES) and all other chemicals. We also lagged
chemical exposures by 10 and 20 years to explore induction/
latency intervals between chemical exposures and prostate
cancer incidence. This was achieved by excluding exposures
received 10 or 20 years prior to the year of diagnosis for the
case and matched controls in each risk set. Finally, we
examined workers from each of the two cohorts separately,
i.e., radiation and aerospace workers.
Survey Population Analysis
We intended to use the survey information to assess
potential confounding due to non-work related risk factors
for prostate cancer. However, the survey population of
workers still alive in 1999 differed considerably from the
cohort population in terms of their occupational histories and
exposures suggesting selection bias. Respondents were more
likely to hold professional/salaried positions (60% vs. 52%),
experienced lower occupational physical activity levels,
and were somewhat more likely to have been exposed to
high levels of chemicals. Thus, we only conducted some
limited analyses evaluating other non-occupational risk
factors reported in the survey. In order to do so we broke
up the risk sets and employed unconditional logistic
regression while controlling for matching variables. We also
examined the distributions of these risk factors across
occupational TCE exposure levels to assess their potential
for confounding.
RESULTS
The most common chemicals workers were exposed
to were PAHs (39%), followed by TCE (37%), hydrazine
(31%), mineral oil (19%) and benzene (13%; Table I).
Cases and controls were relatively similar in terms of
duration of employment, pay status, and occupational
physical activity levels. Yet, generally more cases were
assigned to the highest chemical exposure levels according to
our JEM.
Crude model estimates comparing workers with high
levels of exposure to each chemical to unexposed workers
suggest that high levels of TCE, PAHs and benzene exposure
are related to prostate cancer risk (Table II). However,
including all chemicals, physical activity and SES in our
model resulted in a clear association for only one chemical,
i.e., high TCE exposure still increased the incidence of
prostate cancer more than twofold, and the association
between TCE and prostate cancer appeared dose dependent
(P-value for trend¼ 0.02). Furthermore, the TCE association
increased slightly when exposures were lagged by 20 years.
Lagging exposures by 10 years did not change odds ratio
estimates for all chemical exposures (results not shown).
We also observed a moderate, yet imprecisely estimated
association at high benzene exposure levels, yet lagging
exposures by 20 years removed the association. Lagging
exposures 20 years did not affect associations for other
chemicals. When stratifying by cohort type, results did not
change and supported our overall findings of an association
between TCE exposure and prostate cancer incidence
(zero lag, highest exposure level: radiation cohort OR
[95%CI]: 1.8 [0.66,4.9] and aerospace cohort OR [95%CI]:
1.9 [0.87,4.1]), however, due to the smaller sample size the
estimates are imprecise.
Survey Population Results
Controlling only for matching variables, the following
risk factors were positively associated with prostate
cancer among the 338 workers who participated in the our
survey: African-American race OR[95%CI]¼ 3.6 [0.7, 19],
obesity (BMI 30) OR[95%CI]¼ 2.0 [1.0, 4.2], regular
participation in prostate cancer screening OR[95%CI]¼
2.4 [1.2, 4.8], and having a family history of prostate cancer
OR[95%CI]¼ 3.5 [1.7, 7.0]. Being diabetic was inversely
associated with prostate cancer OR[95%CI]¼ 0.4 [0.2, 0.9].
Obesity and participating in regular prostate cancer screen-
ing did not vary across levels of TCE exposure. Also, TCE
levels did not vary greatly with race and the number of
African American men among workers was very small
(n¼ 7). However, workers with any occupational TCE
exposure were less likely to report a family history of
prostate cancer, and highly exposed workers were about
twice as likely to be diabetic (Table III).
DISCUSSION
Our results suggest that workers with high TCE exposure
were twice as likely to develop prostate cancer as workers
without such exposure, controlling for occupational physical
activity, SES, and occupational exposure to hydrazine,
benzene, PAHs and mineral oil. This association was slightly
stronger when exposures were lagged by 20 years, which
suggests TCE exposure may be involved in the induction of
prostate cancer. The increases in risk observed at high levels
of exposure to benzene and PAHs in crude models mostly
disappeared when we controlled for other chemicals. In fact,
adjustment for TCE exposure was mostly responsible for the
observed changes in estimates. The moderate association for
high benzene exposure in zero lag models disappeared when
exposures were lagged by 20 years. This might suggest that
either benzene exposure is unrelated to prostate cancer
incidence, or might act within a shorter lag or as a promoter
rather than initiator of prostate cancer. However, due to the
small number of benzene exposed subjects, it was not
possible to investigate this association further.
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Few previous epidemiologic studies investigated
associations between prostate cancer and the chemicals
we evaluated. Some studies suggested elevated risks for
aircraft and metal product fabricators and exposures to liquid
fuel combustion products, and lubricating oils and greases
[Van der Gulden et al., 1992; Aronson et al., 1996]. A cohort
study of aerospace workers found the mortality rate of
prostate cancer elevated among those exposed to TCE
[Morgan et al., 1998; RR¼ 1.47 95%CI 0.85 to 2.55]. A
cohort study found a slightly elevated incidence (SIR) of
prostate cancer among workers exposed to TCE [Weiss,
1996]. Very few studies evaluated the potential link
between hydrazine exposure and prostate cancer, and those
that did were cancer mortality investigations [Morris et al.,
1995; Ritz et al., 1999] yielding imprecise and inconclusive
results.
While 40% of our study population was considered
exposed to PAHs, we observed a weak association between
exposure to PAHs and prostate cancer (22–34% increased
risk, with 95% CI including the null value) after adjusting
for exposure to other chemicals. Stronger associations
have been reported in previous studies, possibly because











Mean (median) duration of employment (in years) 18 (16) 19 (19) 18 (15)
Hydrazine exposure levela
None (score¼ 0) 1487 (69) 248 (69) 1239 (69)
Low/moderate (1<score19) 515 (24) 76 (21) 439 (24)
High (Score>19) 165 (7.6) 38 (11) 127 (7.0)
TCE exposure levela
None (score¼ 0) 1374 (63) 227 (63) 1147 (64)
Low/moderate (1<score16) 624 (29) 90 (25) 534 (30)
High (score>16) 169 (7.8) 45 (12) 124 (6.9)
PAHexposure levela
None (score¼ 0) 1313 (61) 218 (60) 1095 (61)
Low/moderate (1<score18) 661 (31) 96 (27) 565 (31)
High (score>18) 193 (8.9) 48 (13) 145 (8.0)
Benzene exposure levela
None (score¼ 0) 1884 (87) 320 (88) 1564 (87)
Low/moderate (1<score19) 216 (10) 24 (6.6) 192 (11)
High (score>19) 67 (3.1) 18 (5.0) 49 (2.7)
Mineral oil exposure levela
None (score¼ 0) 1749 (81) 296 (82) 1453 (81)
Low/moderate (1<score17) 316 (15) 46 (13) 270 (15)
High (score>17) 102 (4.7) 20 (5.5) 82 (4.5)
Cohortb
Radiation 753 (35) 127 (35) 626 (35)
Aerospace 1414 (65) 235 (65) 1179 (65)
Pay status/SES
Professional/salaried 1107 (52) 193 (54) 914 (51)
Non-professional/salaried 701 (33) 104 (29) 597 (34)
Hourly 323 (15) 59 (17) 264 (15)
Occupational physical activitya
Low 904 (42) 148 (41) 756 (42)
Moderate 693 (32) 128 (35) 565 (31)
High 570 (26) 86 (24) 484 (27)
aScores derived from Job exposure matrices and ranges for chemicals derived from quartile cut points.
bRadiation cohort were workers involved in research development of nuclear power systems and aerospace cohort were workers
involved in rocket engine development and testing.
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investigators studied subjects with high exposure to PAHs in
closed environments, e.g., power plant operators [Krstev
et al., 1998], motor mechanics, auto and railway engineers
[Seidler et al., 1998], and boiler room workers [Aronson
et al., 1996]. At this facility, PAHs were mainly generated
through the burning of fossil fuels for jet engines, and
exposures to workers probably occurred mostly outdoors,
which may explain the weak association observed. In
contrast, TCE was mainly used as a solvent, such as for
degreasing engines after testing operations were completed.
These operations were likely to have a high potential for both
dermal and inhalation exposure to TCE.
TABLE III. Comparing Distribution of Potential Confounders AcrossTCE Exposure Levels* (None, Low/Moderate,











African American 0 (0) 1 (2) 1 (3)
Obese (BMI> 30) 11 (11) 7 (10) 5 (16)
Regular prostate cancer screening 82 (82) 53 (79) 24 (77)
Family history of prostate cancer 12 (12) 2 (3) 3 (10)
Diabetic 18 (18) 7 (10) 8 (26)
*Scores derived from JEM.
TABLE II. Crude and Adjusted Conditional Logistic Regression Results for Prostate Cancer Risk by Level of Chemical Exposure Score*, California Aerospace
and RadiationWorkers
Chemical exposure score levels* Crude OR (95%CI) Adjusted OR (95%CI) zero laga Adjusted OR (95%CI) 20 year laga
Hydrazine
Unexposed 1.0 1.0 1.0








Unexposed 1.0 1.0 1.0
Low/Moderate 1.0 (0.82,1.3) 1.3 (0.81,2.1) 1.3 (0.81,2.1)
High 1.8 (1.3,2.5) 2.1 (1.2,3.9) 2.4 (1.3, 4.4)
P trend¼ 0.01 P trend¼ 0.02 P trend¼ 0.01
PAHs
Unexposed 1.0 1.0 1.0
Low/Moderate 1.0 (0.77,1.2) 0.93 (0.61,1.4) 1.0 (0.69,1.6)
High 1.6 (1.2,2.2) 1.2 (0.71,2.1) 1.3 (0.73,2.5)
P trend¼ 0.05 P trend¼ 0.63 P trend¼ 0.43
Benzene
Unexposed 1.0 1.0 1.0
Low/Moderate 0.73 (0.51,1.1) 0.84 (0.52,1.4) 0.86 (0.55,1.3)
High 1.9 (1.2,3.0) 1.5 (0.79,2.8) 1.0 (0.49,2.2)
P trend¼ 0.74 P trend¼ 0.83 P trend¼ 0.74
Mineral Oil
Unexposed 1.0 1.0 1.0
Low/Moderate 1.0 (0.79,1.4) 1.2 (0.80,1.9) 1.2 (0.81,1.9)
High 1.1 (0.65,1.7) 0.72 (0.38,1.4) 0.86 (0.42,1.8)
P trend¼ 0.84 P trend¼ 0.12 P trend¼ 0.93
aAll estimates are adjusted for matching variables (cohort and age at diagnosis), occupational physical activity (low, high), SES (hourly and non-professional/salaried pay status),
and all other chemical exposure levels.
*Scores derived from JEM.
{P-value forTrend.
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A biologically plausible mechanism for the involvement
of specific chemicals in prostate carcinogenesis in humans
has not been established. However, some biologically-based
hypotheses have been generated from the results of animal
studies that experimentally induced prostate tumors; these
include a hormone-mediated pathway, and the disruption of
normal enzymatic activity and/or immune system function.
Diesel engine emissions have been shown to induce changes
in enzymatic activities in the prostate gland of animals
[Seidler et al., 1998]. PAHs or other chemical constituents of
diesel exhaust such as certain hydrocarbons, may also have
hormonal effects with possible carcinogenic potential. In
addition, the antiestrogenic effects of certain hydrocarbons,
such as benzo(a)pyrene, may promote the growth of prostate
cancer cells [Seidler et al., 1998]. However, the clinical
importance of hormonal or other pathways for the prostate
gland invoked for various chemicals, remains inadequately
understood.
Although our survey population was a biased sample of
our entire worker population with respect to occupational
chemical exposures, well-established non-occupational risk
factors, such as black race, regular screening for prostate
cancer, and family history of prostate cancer were associated
with prostate cancer among survey participants. We also
observed a protective effect of diabetes on prostate cancer as
previously reported by Zhu et al. (2004). Due to the selection
bias in our survey population, we were unable to formally
assess confounding due to non-occupational risk factors in
regression models. However, we assessed whether these
other risk factors for prostate cancer were associated with
TCE exposure among control survey participants and found
that this was only the case for family history of prostate
cancer and being diabetic. However, since workers with high
TCE exposure were more likely to have diabetes and less
likely to have a family history of prostate cancer, possible
confounding due to these factors would cause the TCE and
prostate cancer association to be weaker than observed.
The main limitation of any JEM is misclassification of
exposure, i.e., it is possible that a worker with a specific job
title may not be exposed to chemicals to the same degree as
other workers with the same job title. This is especially a
problem for more general job titles found in our worker
population, such as ‘project engineer’ or ‘technician–
member technical staff.’ However, the JEM for this study
was constructed blinded to outcome status; therefore, any
misclassification would likely be non-differential and
result in attenuated risk estimates. Furthermore we used an
industry-based JEM that is expected to have greater
specificity for exposures than a JEM constructed for a
general population [Goldberg et al., 1993].
Although employees worked at the company for a
significant portion of their careers (average duration of
employment was 18 years), some workers may have held
other jobs for a longer period of time. Therefore, they could
have been exposed to different levels of chemicals outside of
this company. If switching to jobs with higher or lower
exposure is related to prostate cancer diagnosis, this would
result in biased estimates. However, workers usually stay in
the same job or change to jobs with similar exposures [Sun
et al., 2003]. Also, most cases were probably retired by the
time they received a prostate cancer diagnosis (mean age at
diagnosis: 68 years; mean age of retirement among survey
participants: 63 years); thus, it is not likely that job changes
were related to diagnosis.
Finally, some of the controls in our population may have
been diagnosed with prostate cancer before 1988. We had
information on prostate cancer diagnoses from four cancer
registries that were in existence before 1988. We found that
there were only 2 previously diagnosed cases that were
selected as controls in our study population (and were
excluded). Therefore, we do not expect we are missing very
many additional cases that occurred before 1988. However,
some controls may have been diagnosed with prostate cancer
between 1988 and 1999 in other states not covered by the
registries from which we collected data. We used national
mortality data to estimate the number of cancers we might
be missing in other states, assuming that prostate cancer
mortality is correlated with prostate cancer incidence, and
cancer incidence rates and exposure distributions are similar
for workers who moved and did not move to non-coverage
states. Since only 12% of prostate cancer deaths that occurred
between 1988 and 1999 in the study population were reported
outside of these states, we estimate that we may be missing
approximately 53 cases of prostate cancer in our two cohorts
together. From among these, however, we expect to have
selected inappropriately no more than 3–5 men as controls;
therefore, we expect the outcome misclassification to be
minimal.
In summary, our data shows that workers at the facility
exposed to high levels of TCE, especially before the late
1970’s, were more likely to develop prostate cancer.
Furthermore, adjustment for other occupational exposures
and lagging of TCE exposures strengthened the observed
associations. Our survey of surviving workers suggested that
lifestyle factors are unlikely to have acted as confounders of
the association.
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